Urology FDA approvals of 2016 February 13, 2017By Urology Times StaffUrology-related FDA approvals from 2016 encompassed drugs and devices for prostate cancer, renal cell carcinoma, bladder cancer, stone disease, and more. New Products: FDA approves combination regimen to treat advanced RCC July 20, 2016By Ben SchwartzOther products discussed in this roundup include a smart-mobile connected ultrasound device, treatments for RCC, and more. RCC: Two approvals expand options for TKI-refractory patients June 29, 2016By Lisette HiltonFDA approval of second-line therapies could mean an “embarrassment of riches” in this field, according to one expert. FDA drug approvals-April 2015 April 06, 2015By Tracey WalkerFDA actions in brief, priority review, breakthrough therapy designation, fast-track designations, orphan drug designations, first-time generic approvals Urology Product Preview
April 30, 2013Drugs and devices in the pipeline from Medivation, Inc.; Astellas Pharma Inc.; TARIS Biomedical; Exelixis, Inc.; and Bioniche Life Sciences Inc.